Supriya Lifescience’s Saloni Wagh On Q4 Performance & Business Outlook | Chartbusters | CNBCTV18
Seems like the management is maturing. This is a much more measured commentary compared to the aggressive guidance given in previous interviews. Looks like they have learnt from the fiascos that were Q2 and Q3.
Disclosure – Invested
| Subscribe To Our Free Newsletter |
